GE HealthCare Technologies Inc.
GE HealthCare Technologies Inc. (GEHCV) Financial Performance & Income Statement Overview
Explore the financials of GE HealthCare Technologies Inc. (GEHCV), including yearly and quarterly data on income, cash flow, and balance sheets.
GE HealthCare Technologies Inc. (GEHCV) Income Statement & Financial Overview
Review GE HealthCare Technologies Inc. GEHCV income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $5.32B | $4.86B | $4.84B | $4.65B |
| Cost of Revenue | $3.04B | $2.84B | $2.84B | $2.75B |
| Gross Profit | $2.27B | $2.02B | $2.00B | $1.90B |
| Gross Profit Ratio | $0.43 | $0.42 | $0.41 | $0.41 |
| R&D Expenses | $344.00M | $316.00M | $327.00M | $324.00M |
| SG&A Expenses | $1.13B | $1.03B | $1.004B | $1.04B |
| Operating Expenses | $1.47B | $1.35B | $1.33B | $1.36B |
| Total Costs & Expenses | $4.52B | $4.19B | $4.17B | $4.11B |
| Interest Income | $0.00 | $5.00M | $0.00 | $0.00 |
| Interest Expense | $111.00M | $130.00M | $131.00M | $138.00M |
| Depreciation & Amortization | $140.00M | $143.00M | $150.00M | $148.00M |
| EBITDA | $1.08B | $933.00M | $862.00M | $792.00M |
| EBITDA Ratio | $0.20 | $0.19 | $0.17 | $0.17 |
| Operating Income | $801.00M | $676.00M | $664.00M | $540.00M |
| Operating Income Ratio | $0.15 | $0.14 | $0.14 | $0.12 |
| Other Income/Expenses (Net) | $33.00M | -$18.00M | -$86.00M | -$28.00M |
| Income Before Tax | $834.00M | $658.00M | $578.00M | $512.00M |
| Income Before Tax Ratio | $0.16 | $0.14 | $0.12 | $0.11 |
| Income Tax Expense | $96.00M | $168.00M | $143.00M | $124.00M |
| Net Income | $720.00M | $471.00M | $428.00M | $374.00M |
| Net Income Ratio | $0.14 | $0.10 | $0.09 | $0.08 |
| EPS | $1.58 | $1.03 | $0.94 | $0.82 |
| Diluted EPS | $1.57 | $1.02 | $0.93 | $0.81 |
| Weighted Avg Shares Outstanding | $457.00M | $457.00M | $457.00M | $456.00M |
| Weighted Avg Shares Outstanding (Diluted) | $459.00M | $459.00M | $459.00M | $459.00M |
Over the past four quarters, GE HealthCare Technologies Inc. demonstrated steady revenue growth, increasing from $4.65B in Q1 2024 to $5.32B in Q4 2024. Operating income reached $801.00M in Q4 2024, maintaining a consistent 15% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $1.08B, reflecting operational efficiency. Net income rose to $720.00M, with EPS at $1.58. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan